Moreover, RXRA, TRAP220/MED1 and HNF6/ONECUT1 were primarily up‐regulated in MASLD cases with decreased FGF21 expression (Figure 2B). Here, FGF21 is linked to metabolic dysfunction-associated steatotic liver disease.